IL161966A0 - Aryloxyphenyl and arylsulfanylphenyl - Google Patents
Aryloxyphenyl and arylsulfanylphenylInfo
- Publication number
- IL161966A0 IL161966A0 IL16196602A IL16196602A IL161966A0 IL 161966 A0 IL161966 A0 IL 161966A0 IL 16196602 A IL16196602 A IL 16196602A IL 16196602 A IL16196602 A IL 16196602A IL 161966 A0 IL161966 A0 IL 161966A0
- Authority
- IL
- Israel
- Prior art keywords
- arylsulfanylphenyl
- aryloxyphenyl
- compounds
- valuable
- substituents
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34265301P | 2001-12-20 | 2001-12-20 | |
| DKPA200101927 | 2001-12-20 | ||
| PCT/DK2002/000859 WO2003053942A1 (en) | 2001-12-20 | 2002-12-16 | Aryloxyphenyl and arylsulfanylphenyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161966A0 true IL161966A0 (en) | 2005-11-20 |
Family
ID=26069114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16196602A IL161966A0 (en) | 2001-12-20 | 2002-12-16 | Aryloxyphenyl and arylsulfanylphenyl |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7067501B2 (de) |
| EP (1) | EP1458689B1 (de) |
| JP (1) | JP2005513128A (de) |
| CN (1) | CN100457738C (de) |
| AT (1) | ATE359276T1 (de) |
| AU (1) | AU2002351734A1 (de) |
| CA (1) | CA2467118A1 (de) |
| DE (1) | DE60219521T2 (de) |
| ES (1) | ES2280595T3 (de) |
| HU (1) | HUP0402320A2 (de) |
| IL (1) | IL161966A0 (de) |
| IS (1) | IS7258A (de) |
| MX (1) | MXPA04005989A (de) |
| NO (1) | NO20042885L (de) |
| WO (1) | WO2003053942A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| CA2536275A1 (en) * | 2003-08-21 | 2005-03-03 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
| WO2005058885A2 (en) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Piperidine derivatives and their use as glycine transporter inhibitors |
| WO2005058317A1 (en) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Glycine transporter-1 inhibirors |
| CA2553938A1 (en) * | 2004-01-08 | 2005-07-28 | F. Hoffmann-La Roche Ag | Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2 |
| WO2006000222A2 (en) * | 2004-06-24 | 2006-01-05 | H. Lundbeck A/S | The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia |
| US7485637B2 (en) * | 2005-01-04 | 2009-02-03 | Hoffmann-La Roche Inc. | Benzoyl-tetrahydropiperidine derivatives |
| MY150647A (en) | 2006-06-16 | 2014-02-14 | Lundbeck & Co As H | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| SG172685A1 (en) | 2006-06-28 | 2011-07-28 | Amgen Inc | Glycine transporter-1 inhibitors |
| TW200848411A (en) * | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
| CN101784533B (zh) | 2007-08-22 | 2013-08-21 | 艾博特股份有限两合公司 | 4-苄基氨基喹啉、含有它们的药物组合物和它们在治疗中的用途 |
| TW200932233A (en) * | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
| AU2008335788B2 (en) * | 2007-12-12 | 2012-11-29 | Amgen Inc. | Glycine transporter-1 inhibitors |
| EP2271625B1 (de) | 2008-04-01 | 2012-09-12 | Abbott GmbH & Co. KG | Tetrahydroisochinoline, pharmazeutische zusammensetzungen damit und ihre therapeutische verwendung |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| TW201038569A (en) | 2009-02-16 | 2010-11-01 | Abbott Gmbh & Co Kg | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| EP2539706B1 (de) * | 2010-02-24 | 2015-03-04 | Research Triangle Institute | Arylpiperazin-opioid-rezeptor-antagonisten |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| MX2014001457A (es) | 2011-08-05 | 2014-08-21 | Abbvie Deutschland | Derivados de aminocromano, de aminotiocromano y de amino-1,2,3,4-tetrahidroquinolina composiciones farmaceuticas que los contienen, y su uso en terapia. |
| WO2013072520A1 (en) | 2011-11-18 | 2013-05-23 | AbbVie Deutschland GmbH & Co. KG | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| MX344144B (es) * | 2012-01-03 | 2016-12-07 | H Lundbeck As | Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)feni l] piperazina. |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| HRP20170607T1 (hr) * | 2013-02-22 | 2017-06-30 | H. Lundbeck A/S | Proizvodni postupak vortioksetina |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CA2924689A1 (en) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| JP2016533375A (ja) | 2013-10-17 | 2016-10-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用 |
| US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
| KR101753617B1 (ko) | 2016-05-10 | 2017-07-11 | 주식회사 뉴로벤티 | 피페라진-1-카복사미딘 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 자폐 범주성 장애 예방 및 치료용 약학적 조성물 |
| WO2017215636A1 (zh) | 2016-06-16 | 2017-12-21 | 广东东阳光药业有限公司 | 二芳基硫醚哌嗪类化合物及其制备方法和用途 |
| CN106279071B (zh) * | 2016-08-10 | 2019-01-04 | 广东东阳光药业有限公司 | 苯基哌嗪衍生物及其使用方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5730738A (en) | 1995-12-04 | 1998-03-24 | The Procter & Gamble Company | Absorbent article with angled band structural elastic-like film cuffs |
| JPH10152470A (ja) * | 1996-09-25 | 1998-06-09 | Yoshitomi Pharmaceut Ind Ltd | ピペラジン化合物 |
| AU726447B2 (en) * | 1996-10-21 | 2000-11-09 | Neurosearch A/S | 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulators |
| CA2536275A1 (en) * | 2003-08-21 | 2005-03-03 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
-
2002
- 2002-12-16 EP EP02787451A patent/EP1458689B1/de not_active Expired - Lifetime
- 2002-12-16 HU HU0402320A patent/HUP0402320A2/hu unknown
- 2002-12-16 ES ES02787451T patent/ES2280595T3/es not_active Expired - Lifetime
- 2002-12-16 CN CNB028257022A patent/CN100457738C/zh not_active Expired - Fee Related
- 2002-12-16 JP JP2003554658A patent/JP2005513128A/ja active Pending
- 2002-12-16 MX MXPA04005989A patent/MXPA04005989A/es unknown
- 2002-12-16 WO PCT/DK2002/000859 patent/WO2003053942A1/en not_active Ceased
- 2002-12-16 IL IL16196602A patent/IL161966A0/xx unknown
- 2002-12-16 CA CA002467118A patent/CA2467118A1/en not_active Abandoned
- 2002-12-16 AT AT02787451T patent/ATE359276T1/de not_active IP Right Cessation
- 2002-12-16 AU AU2002351734A patent/AU2002351734A1/en not_active Abandoned
- 2002-12-16 DE DE60219521T patent/DE60219521T2/de not_active Expired - Fee Related
-
2004
- 2004-05-10 IS IS7258A patent/IS7258A/is unknown
- 2004-05-20 US US10/851,769 patent/US7067501B2/en not_active Expired - Fee Related
- 2004-07-07 NO NO20042885A patent/NO20042885L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE359276T1 (de) | 2007-05-15 |
| HK1076807A1 (zh) | 2006-01-27 |
| MXPA04005989A (es) | 2004-09-27 |
| AU2002351734A1 (en) | 2003-07-09 |
| EP1458689A1 (de) | 2004-09-22 |
| US7067501B2 (en) | 2006-06-27 |
| CA2467118A1 (en) | 2003-07-03 |
| EP1458689B1 (de) | 2007-04-11 |
| DE60219521T2 (de) | 2007-08-16 |
| HUP0402320A2 (hu) | 2005-03-29 |
| IS7258A (is) | 2004-05-10 |
| CN100457738C (zh) | 2009-02-04 |
| DE60219521D1 (de) | 2007-05-24 |
| ES2280595T3 (es) | 2007-09-16 |
| JP2005513128A (ja) | 2005-05-12 |
| WO2003053942A1 (en) | 2003-07-03 |
| CN1606548A (zh) | 2005-04-13 |
| NO20042885L (no) | 2004-07-07 |
| US20050171061A1 (en) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042885L (no) | Aryloksyfenyl- og arylsulfanylfenylderivater | |
| PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
| PL369530A1 (en) | Chemical compounds | |
| IL163777A0 (en) | Kinase inhibitors | |
| CY1109006T1 (el) | Παραγωγα πουρινης ως αναστολεις κινασης | |
| ZA200704910B (en) | Pyrrolidine inhibitors of IAP | |
| GEP20105081B (en) | Pyrrolotriazine compounds as kinase inhibitors | |
| TW200640924A (en) | VEGF-R2 inhibitors and methods | |
| GB0130341D0 (en) | Compounds | |
| MY130718A (en) | Antitumor compounds and methods | |
| CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
| GEP20074215B (en) | Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof | |
| MY133969A (en) | Indoloquinazolinones | |
| ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
| MXPA04006266A (es) | Pirimidotriazinas como inhibidores de fosfatasa. | |
| AU2003290592A1 (en) | Antitumor benzoylsulfonamides | |
| SE0103710D0 (sv) | Compounds | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| DE60204701D1 (de) | Tricyclische imidazopyridine | |
| EA201270630A1 (ru) | Гетероциклические сетр ингибиторы | |
| UA85505C2 (en) | Kinase inhibitors | |
| MY128164A (en) | Compounds | |
| SI1377574T1 (de) | ||
| MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. | |
| MXPA06000372A (es) | Compuestos de silicio y su uso. |